about
{gamma}-Globin gene expression in chemical inducer of dimerization (CID)-dependent multipotential cells established from human {beta}-globin locus yeast artificial chromosome ({beta}-YAC) transgenic miceTowards in vivo amplification: Overcoming hurdles in the use of hematopoietic stem cells in transplantation and gene therapyAn inducible, ligand-independent receptor activator of NF-κB gene to control osteoclast differentiation from monocytic precursorsJAK2, complemented by a second signal from c-kit or flt-3, triggers extensive self-renewal of primary multipotential hemopoietic cells.Advances in gene transfer into haematopoietic stem cells by adenoviral vectors.Long-term regulation of genetically modified primary hematopoietic cells in dogs.Growth factor receptors as regulators of hematopoiesis.Gene therapy with drug resistance genes.Survival of the fittest: in vivo selection and stem cell gene therapyErythropoietic agents and the elderly.Using gene transfer to circumvent off-target effects.Protein engineering for cardiovascular therapeutics: untapped potential for cardiac repair.Construction of unnatural heterodimeric receptors based on IL-2 and IL-6 receptor subunits.Methylguanine methyltransferase-mediated in vivo selection and chemoprotection of allogeneic stem cells in a large-animal model.Protein interface remodeling in a chemically induced protein dimer.Death switch for gene therapy: application to erythropoietin transgene expression.Expansion of genetically corrected neutrophils in chronic granulomatous disease mice by cotransferring a therapeutic gene and a selective amplifier gene.Anatomical compartments modify the response of human hematopoietic cells to a mitogenic signal.
P2860
Q24318989-DA58009D-72E2-464E-A6C2-269EE180EA15Q26771159-5A414F1D-D420-46B0-86AD-81E734943C5EQ28538066-5D6D58BE-7CCC-451C-B0B1-C568225FAEE5Q34087180-D256F471-0620-4711-A4CF-D3FDA2ED666DQ35040833-116D9422-F817-4BCB-924C-38ED1D135ADCQ35086136-C681E9C3-3F34-46D8-B138-DA39DBC33842Q35848814-53B55F6D-53E3-426F-8BD9-CEF97D8D5025Q36279821-A1CA438D-AFED-43BE-9FF6-0C44A4E7E66DQ36306141-C5317FCA-9780-4192-B362-1CD177760C98Q37098040-5198E7DC-0164-447F-89FA-1312B2301ECEQ37115387-B400EC51-8E4E-4B21-83CA-2E825482FB2DQ37405644-820B4E8F-CA84-40B1-B9B4-87CA7E2FC4A5Q39113674-0D7AF4A8-217B-4C92-98D6-D4D30C9EC6BFQ40156537-C32869F4-F8E9-43FD-9837-60E4B79F5C3CQ41502945-E5001A1A-3443-4946-AB47-346AE475DA80Q43055175-76D8FAE9-4EF9-4BC1-A0B9-2EF2E21B9A46Q44960585-BADF2939-741F-4F7C-8191-825B5F7E40E6Q46864865-08025838-ECFD-46D8-A97A-4F9B2011BB97
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pharmacologically regulated cell therapy.
@ast
Pharmacologically regulated cell therapy.
@en
Pharmacologically regulated cell therapy.
@nl
type
label
Pharmacologically regulated cell therapy.
@ast
Pharmacologically regulated cell therapy.
@en
Pharmacologically regulated cell therapy.
@nl
prefLabel
Pharmacologically regulated cell therapy.
@ast
Pharmacologically regulated cell therapy.
@en
Pharmacologically regulated cell therapy.
@nl
P356
P1433
P1476
Pharmacologically regulated cell therapy.
@en
P304
P356
10.1182/BLOOD.V97.9.2535
P407
P577
2001-05-01T00:00:00Z